article_snippet: Dr Alison Birtle, consultant clinical oncologist at Lancashire Teaching Hospitals NHS Foundation Trust, said the decision to axe
article_snippet: Jevtana was a travesty.
article_snippet: In my every day experience, Jevtana has given some men with advanced prostate cancer extra time
article_snippet: – some of the men that I started to treat with Jevtana three to four years ago are still alive today.
article_snippet: ‘Most importantly this time has been of good quality, allowing some of the men that I started to treat with Jevtana three to four years ago to carry on doing the things some of the men that I started to treat with Jevtana three to four years ago enjoy despite some of the men that I started to treat with Jevtana three to four years ago cancer.
article_snippet: ’ Hugh Gunn, spokesperson for prostate cancer patients’ charity TACKLE, said the removal of Jevtana, also known as cabazitaxel was a terrible blow.
article_snippet: ’ Tarja Stenvall, General Manager for Sanofi in the UK, said Sanofi was continuing a ‘dialogue’ with England to explore immediate ways of maintaining access to patients for Jevtana.